|
1
|
Krane SM: Identifying genes that regulate
bone remodeling as potential therapeutic targets. J Exp Med.
201:841–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crane JL and Cao X: Bone marrow
mesenchymal stem cells and TGF-β signaling in bone remodeling. J
Clin Invest. 124:466–472. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li CJ, Cheng P, Liang MK, Chen YS, Lu Q,
Wang JY, Xia ZY, Zhou HD, Cao X, Xie H, et al: MicroRNA-188
regulates age-related switch between osteoblast and adipocyte
differentiation. J Clin Invest. 125:1509–1522. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khalaj M, Woolthuis CM, Hu W, Durham BH,
Chu SH, Qamar S, Armstrong SA and Park CY: miR-99 regulates normal
and malignant hematopoietic stem cell self-renewal. J Exp Med. Jul
21–2017.(Epub ahead of print). jem.20161595, 2017. doi:
10.1084/jem.20161595. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Edmonds MD, Boyd KL, Moyo T, Mitra R,
Duszynski R, Arrate MP, Chen X, Zhao Z, Blackwell TS, Andl T and
Eischen CM: MicroRNA-31 initiates lung tumorigenesis and promotes
mutant KRAS-driven lung cancer. J Clin Invest. 126:349–364. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mori MA, Thomou T, Boucher J, Lee KY,
Lallukka S, Kim JK, Torriani M, Yki-Järvinen H, Grinspoon SK,
Cypess AM and Kahn CR: Altered miRNA processing disrupts
brown/white adipocyte determination and associates with
lipodystrophy. J Clin Invest. 124:3339–3351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou X, Jeker LT, Fife BT, Zhu S, Anderson
MS, McManus MT and Bluestone JA: Selective miRNA disruption in T
reg cells leads to uncontrolled autoimmunity. J Exp Med.
205:1983–1991. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li H, Xie H, Liu W, Hu R, Huang B, Tan YF,
Xu K, Sheng ZF, Zhou HD, Wu XP and Luo XH: A novel microRNA
targeting HDAC5 regulates osteoblast differentiation in mice and
contributes to primary osteoporosis in humans. J Clin Invest.
119:3666–3677. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Z, Hassan MQ, Volinia S, van Wijnen AJ,
Stein JL, Croce CM, Lian JB and Stein GS: A microRNA signature for
a BMP2-induced osteoblast lineage commitment program. Proc Natl
Acad Sci USA. 105:13906–13911. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gu H, Xu J, Huang Z, Wu L, Zhou K, Zhang
Y, Chen J, Xia J and Yin X: Identification and differential
expression of microRNAs in 1, 25-dihydroxyvitamin D3-induced
osteogenic differentiation of human adipose-derived mesenchymal
stem cells. Am J Transl Res. 11:4856–4871. 2017.
|
|
12
|
Maruyama K, Uematsu S, Kondo T, Takeuchi
O, Martino MM, Kawasaki T and Akira S: Strawberry notch homologue 2
regulates osteoclast fusion by enhancing the expression of
DC-STAMP. J Exp Med. 210:1947–1960. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Javed A, Gutierrez S, Montecino M, van
Wijnen AJ, Stein JL, Stein GS and Lian JB: Multiple Cbfa/AML sites
in the rat osteocalcin promoter are required for basal and vitamin
D-responsive transcription and contribute to chromatin
organization. Mol Cell Biol. 19:7491–7500. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, He X, Wei W and Zhou X: MicroRNA-194
promotes osteoblast differentiation via downregulating STAT1.
Biochem Biophys Res Commun. 460:482–488. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zou W, Greenblatt MB, Brady N, Lotinun S,
Zhai B, de Rivera H, Singh A, Sun J, Gygi SP, Baron R, et al: The
microtubule-associated protein DCAMKL1 regulates osteoblast
function via repression of RUNX2. J Exp Med. 210:1793–1806. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao WZ, Gu XC, Hu B, Liu XW, Zi Y and Li
M: Role of microRNA-129-5p in osteoblast differentiation from bone
marrow mesenchymal stem cells. Cell Mol Biol (Noisy-le-grand).
62:95–99. 2016.PubMed/NCBI
|
|
18
|
Grünhagen J, Bhushan R, Degenkolbe E,
Jäger M, Knaus P, Mundlos S, Robinson PN and Ott CE: miR-497
approximately 195 cluster microRNAs regulate osteoblast
differentiation by targeting BMP signaling. J Bone Miner Res.
30:796–808. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bertero T, Gastaldi C, Bourget-Ponzio I,
Imbert V, Loubat A, Selva E, Busca R, Mari B, Hofman P, Barbry P,
et al: miR-483-3p controls proliferation in wounded epithelial
cells. FASEB J. 25:3092–3105. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lupini L, Pepe F, Ferracin M, Braconi C,
Callegari E, Pagotto S, Spizzo R, Zagatti B, Lanuti P, Fornari F,
et al: Over-expression of the miR-483-3p overcomes the miR-145/TP53
pro-apoptotic loop in hepatocellular carcinoma. Oncotarget.
7:31361–31371. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim S, Koga T, Isobe M, Kern BE, Yokochi
T, Chin YE, Karsenty G, Taniguchi T and Takayanagi H: Stat1
functions as a cytoplasmic attenuator of RUNX2 in the
transcriptional program of osteoblast differentiation. Genes Dev.
17:1979–1991. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bertero T, Bourget-Ponzio I, Puissant A,
Loubat A, Mari B, Meneguzzi G, Auberger P, Barbry P, Ponzio G and
Rezzonico R: Tumor suppressor function of miR-483-3p on squamous
cell carcinomas due to its pro-apoptotic properties. Cell Cycle.
12:2183–2193. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ferland-McCollough D, Fernandez-Twinn DS,
Cannell IG, David H, Warner M, Vaag AA, Bork-Jensen J, Brøns C,
Gant TW, Willis AE, et al: Programming of adipose tissue miR-483-3p
and GDF-3 expression by maternal diet in type 2 diabetes. Cell
Death Differ. 19:1003–1012. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meraz MA, White JM, Sheehan KC, Bach EA,
Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D,
et al: Targeted disruption of the Stat1 gene in mice reveals
unexpected physiologic specificity in the JAK-STAT signaling
pathway. Cell. 84:431–442. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang Z, Richmond TD, Muntean AG, Barber
DL, Weiss MJ and Crispino JD: STAT1 promotes megakaryopoiesis
downstream of GATA-1 in mice. J Clin Invest. 117:3890–3899. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takayanagi H, Ogasawara K, Hida S, Chiba
T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, et al:
T-cell-mediated regulation of osteoclastogenesis by signalling
cross-talk between RANKL and IFN-gamma. Nature. 408:600–605. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tajima K, Takaishi H, Takito J, Tohmonda
T, Yoda M, Ota N, Kosaki N, Matsumoto M, Ikegami H, Nakamura T, et
al: Inhibition of STAT1 accelerates bone fracture healing. J Orthop
Res. 28:937–941. 2010.PubMed/NCBI
|
|
28
|
Slemenda C, Longcope C, Peacock M, Hui S
and Johnston CC: Sex steroids, bone mass, and bone loss. A
prospective study of pre-, peri-, and postmenopausal women. J Clin
Invest. 97:14–21. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lane NE, Sanchez S, Modin GW, Genant HK,
Pierini E and Arnaud CD: Parathyroid hormone treatment can reverse
corticosteroid-induced osteoporosis. Results of a randomized
controlled clinical trial. J Clin Invest. 102:1627–1633. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Balani DH, Ono N and Kronenberg HM:
Parathyroid hormone regulates fates of murine osteoblast precursors
in vivo. J Clin Invest. 127:3327–3338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang X, Guo B, Li Q, Peng J, Yang Z, Wang
A, Li D, Hou Z, Lv K, Kan G, et al: miR-214 targets ATF4 to inhibit
bone formation. Nat Med. 19:93–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
